Green, D W <br/><br/>
Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.  [electronic resource] 

 -  The Journal of surgical research  Nov 2001 
 - 16-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1006/jsre.2001.6241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma--genetics<br/>Colonic Neoplasms--genetics<br/>Cytoskeletal Proteins--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Female<br/>Genes, APC<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mutation<br/>Neoplasm Transplantation<br/>Oligonucleotides, Antisense--pharmacology<br/>Trans-Activators<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured--transplantation<br/>beta Catenin